Omnicare (OCR) 86.11 $OCR Health of Health Care Stocks:

New Post Public Reply Private Reply Replies (0) Message Board

Apr 26, 2015 at 3:10 PM

Omnicare (OCR) 86.11 $OCR

Health of Health Care Stocks: Complementary Research on Enzon Pharmaceuticals, Durect Corporation, Vertex Pharmaceuticals, Advaxis, and Omnicare
PR Newswire - Fri Apr 24, 7:30AM CDT
Editor Note: For more information about this release, please scroll to bottom.
ENZN: 1.72 (+0.18), OCR: 86.11 (-0.20), ADXS: 23.34 (-0.27), VRTX: 133.20 (-2.62), DRRX: 2.11 (-0.46)

Downgrade Alert for Omnicare (OCR)
Comtex SmarTrend(R) - Fri Apr 24, 7:12AM CDT
Omnicare (NYSE:OCR) was downgraded from Outperform to Sector Perform at RBC Capital today. The stock closed yesterday at $86.31 on volume of 3.9 million shares, above average daily volume of 642,000. Omnicare, Inc. provides geriatric pharmaceutical services. The Company distributes pharmaceuticals, and provides related pharmacy consulting and other ancillary services, data management services and medical supplies to skilled nursing facilities, assisted living facilities, retirement centers, independent living communities, hospitals, hospice, and other healthcare providers.
OCR: 86.11 (-0.20)

NYSE stocks posting largest volume increases
AP - Thu Apr 23, 5:05PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
AEC: 28.45 (+0.04), VSI: 42.98 (-0.15), DLB: 40.61 (-0.65), OCR: 86.11 (-0.20), SAR: 16.45 (-0.04), SKX: 89.66 (+2.79), TRMR: 2.88 (-0.04), CMG: 637.50 (+1.90), DPZ: 113.96 (+4.73), ADPT: 63.78 (+2.13), PKG: 70.00 (-0.04)

One Factor Driving Omnicare (OCR) Stock Up Today
at The Street - Thu Apr 23, 11:15AM CDT
Omnicare (OCR) shares gain after a report that the company is exploring a possible sale.
OCR: 86.11 (-0.20)

Omnicare buyer would need to pay $95/share - UBS
Seeking Alpha - at Seeking Alpha - Thu Apr 23, 6:41AM CDT

OCR: 86.11 (-0.20), WBA: 85.98 (-0.71), RAD: 8.25 (-0.01)

Wall Street Breakfast: Where's The Value These Days?
Wall Street Breakfast - at Seeking Alpha - Thu Apr 23, 5:27AM CDT

CXO: 125.84 (-0.64), PZN: 9.25 (+0.05), OCR: 86.11 (-0.20), BTG: 1.55 (-0.03), HL: 3.04 (-0.06), AUQ: 3.43 (-0.11), SKX: 89.66 (+2.79), CNQ: 33.62 (-0.01), INTC: 32.08 (-0.27), GOOG: 565.06 (+18.06), RRC: 61.36 (-0.58), NOK: 7.76 (-0.09), UUUU: 5.30 (-0.12), PBR: 9.99 (+0.59), URRE: 1.41 (-0.05), KGC: 2.30 (-0.01), GSM: 21.17 (+0.17), DNN: 0.95 (-0.02), SLW: 19.16 (-0.19), EOG: 96.72 (-1.55), TMUS: 34.31 (-0.13), SIRI: 3.96 (+0.03), MA: 90.72 (-0.16), AEC: 28.45 (+0.04), HAR: 145.10 (-1.39), GOLD: 74.55 (-1.54), FB: 81.53 (-0.88), NCR: 28.88 (-1.01), AU: 10.65 (-0.47), IAG: 2.12 (-0.03), MCP: 0.99 (+0.15), BA: 148.40 (-1.47), AVL: 0.30 (+0.01), IWB: 118.66 (+0.17), NG: 3.58 (-0.04), NFX: 38.76 (+0.72), PXD: 174.10 (-1.06), OSN: 0.70 (-0.03), TXN: 54.73 (+0.01), FNV: 49.24 (-1.07), PAAS: 9.18 (-0.15), MCD: 98.74 (+1.74), RGLD: 62.30 (-1.76), MRO: 30.33 (-0.22), AUY: 3.83 (-0.10), NVS: 104.28 (-1.22), KMI: 44.34 (-0.23), DHI: 26.57 (+0.42), CCJ: 17.30 (+0.03), CLR: 51.35 (-1.25), GFI: 4.10 (-0.19), LVS: 55.25 (+0.13), REMX: 27.59 (+0.33), URZ: 1.25 (-0.04), SU: 33.06 (+0.08), T: 34.01 (-0.22), UEC: 2.31 (-0.09), ECA: 14.00 (-0.04), XLP: 49.19 (+0.01), GMO: 0.80 (-0.04), V: 67.48 (-0.24), EBAY: 59.20 (+0.31), EGO: 4.70 (-0.20), S: 5.27 (+0.03), BHP: 51.04 (+1.82), TRN: 28.70 (-4.66), QCOM: 68.24 (-0.10), ANGI: 6.16 (-0.24), URG: 1.04 (+0.01), GOOGL: 573.66 (+16.20), EMC: 26.50 (-0.09), TWC: 155.26 (+6.50), AGI: 6.71 (-0.11), XLF: 24.28 (-0.04), AAPL: 130.28 (+0.61), REE: 0.76 (-0.03), APC: 92.65 (-0.81), KO: 40.89 (-0.06), BAM: 55.58 (+0.03), AMZN: 445.10 (+55.11), ABT: 48.32 (-0.14), ABX: 12.52 (-0.12), NEM: 24.98 (+1.53), DB: 34.26 (+0.11), ASML: 107.16 (-1.53), XLV: 74.39 (-0.24), VSI: 42.98 (-0.15), BIDU: 216.90 (+4.62), ARRS: 35.76 (-1.54), LEU: 5.22 (+0.58), CMCSA: 59.64 (+0.41), SBGL: 8.64 (-0.72), GG: 19.01 (-0.51), BABA: 84.57 (+2.29)

Omnicare
at Investor's Business Daily - Wed Apr 22, 5:22PM CDT
Omnicare (OCR) rose 4.3% to 84.52, hitting a record 90.49 intraday, after Bloomberg reported that the nursing-home pharmacy firm is mulling a move to sell the company.
OCR: 86.11 (-0.20)

Why Omnicare Inc. Shares Soared Today
Todd Campbell, The Motley Fool - Motley Fool - Wed Apr 22, 4:21PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Omnicare shares surged higher today...
OCR: 86.11 (-0.20)

Omnicare reportedly exploring sale; trading halted
Seeking Alpha - at Seeking Alpha - Wed Apr 22, 2:33PM CDT

ABT: 48.32 (-0.14), OCR: 86.11 (-0.20)

Critical Alerts For Linn Energy, HealthStream, Palo Alto Networks, Ominicare and DIRECTV Released By InvestorsObserver
PR Newswire - Wed Apr 22, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for LINE, HSTM, PANW, OCR and DTV.
OCR: 86.11 (-0.20), DTV: 89.85 (-0.27), HSTM: 31.02 (+0.88), LINE: 13.56 (-0.05), PANW: 153.84 (-0.94)

Omnicare (OCR) Catches Eye: Stock Rises 5.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 8:11AM CDT
Omnicare Inc. (OCR) was a big mover last session, as the company saw its shares rise over 5% on the day.
OCR: 86.11 (-0.20), XON: 44.10 (-0.91)

NYSE stocks posting largest percentage increases
AP - Tue Apr 21, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
OCR: 86.11 (-0.20), ATI: 34.61 (+0.05), GNE: 11.37 (+0.70), KMB: 111.64 (-0.06), KNL: 23.26 (+0.26), OXM: 79.94 (-0.16), VOC: 6.20 (-0.18), PANW: 153.84 (-0.94), IMPR: 14.85 (-0.16), LRE: 8.69 (+0.11), AMBR: 9.02 (-0.08), DMD: 6.55 (-0.13), GLPW: 12.20 (-0.32), PAYC: 32.91 (-0.14)

Omnicare Set to Possibly Pullback After Yesterday's Rally of 5.23%
Comtex SmarTrend(R) - Tue Apr 21, 4:57PM CDT
Omnicare (NYSE:OCR) traded in a range yesterday that spanned from a low of $77.13 to a high of $81.73. Yesterday, the shares gained 5.2%, which took the trading range above the 3-day high of $78.01 on volume of 2.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
OCR: 86.11 (-0.20)

Barbarian At The Gate: Omnicare (OCR)
at The Street - Tue Apr 21, 1:29PM CDT
Trade-Ideas LLC identified Omnicare (OCR) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
OCR: 86.11 (-0.20)

Omnicare Shares Up 22.6% Since SmarTrend's Buy Recommendation (OCR)
Comtex SmarTrend(R) - Tue Apr 21, 11:38AM CDT
SmarTrend identified an Uptrend for Omnicare (NYSE:OCR) on October 21st, 2014 at $63.85. In approximately 6 months, Omnicare has returned 22.55% as of today's recent price of $78.25.
OCR: 86.11 (-0.20)

December 18th Options Now Available For Omnicare (OCR)
DividendChannel.com - Mon Apr 20, 11:47AM CDT
Investors in Omnicare Inc. saw new options become available today, for the December 18th expiration.
OCR: 86.11 (-0.20)

Shares of OCR Up 21.7% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue Apr 14, 9:57AM CDT
SmarTrend identified an Uptrend for Omnicare (NYSE:OCR) on October 21st, 2014 at $63.85. In approximately 6 months, Omnicare has returned 21.68% as of today's recent price of $77.69.
OCR: 86.11 (-0.20)

Omnicare Moves Up In Market Cap Rank, Passing Goodyear Tire & Rubber
TheOnlineInvestor.com - Wed Apr 08, 4:07PM CDT
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Omnicare Inc. was identified as having a larger market cap than the smaller end of the S&P 500, for example Goodyear Tire & Rubber Co.
OCR: 86.11 (-0.20)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Apalutamide Boosts Outlook for Prostate Cancer Treatment

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

What to Expect: Your First Therapy Session Insights

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Aluminum Design Fumble: Geometry Over Wall Thickness

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

DIRECTV Bags New NHL Deals: Stakes for Sports Fans

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Master Sommeliers and Italian Producers Clash on Wine Lists

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Axon Body 5: A Leap Forward in AI for Public Safety

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...